TSXV - Delayed Quote CAD
Thiogenesis Therapeutics, Corp. (TTI.V)
0.6200
0.0000
(0.00%)
At close: 3:54:11 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Johnson (Neil CFA) Director of Issuer | Exercise of options | Mar 22, 2022 | 875,000 |
| Mullally (W Hogan) Director of Issuer | Exercise of options | Mar 30, 2022 | 875,000 |
| Riggins (Brook) Director of Issuer | Acquisition or disposition in the public market | Aug 2, 2022 | 1,000,000 |
| Rioux (Patrice P) 10% Security Holder of Issuer | Opening Balance-Initial SEDI Report | Mar 31, 2022 | 6,737,869 |
| Stanton (Vincent Paul Jr., M.D.) 10% Security Holder of Issuer | Opening Balance-Initial SEDI Report | Apr 5, 2022 | 4,000,000 |
Related Tickers
BETR.CN BetterLife Pharma Inc.
0.0950
+5.56%
GBLX GB Sciences, Inc.
0.0002
0.00%
SVA.TO Sernova Biotherapeutics Inc
0.2000
-2.44%
DBVT DBV Technologies S.A.
9.39
+1.51%
MCRB Seres Therapeutics, Inc.
8.55
-7.37%
TIL Instil Bio, Inc.
12.70
-9.61%
ALGS Aligos Therapeutics, Inc.
4.5800
-9.31%
AUPH Aurinia Pharmaceuticals Inc.
8.12
-1.69%
LQDA Liquidia Corporation
15.54
-3.63%
SANA Sana Biotechnology, Inc.
1.7100
-8.56%